The result of our experiments was suggestive of the significant elevation in the mRNA expression level of PPARγ in non‐M3 AML patients at diagnosis as compared with the healthy counterparts; suggesting that probably the activation of PPARγ in leukemic cells could act against the survival of cancer cells. This evidence concerns the gene PPARG and cancer.